Grant Funding Opportunities: 1/9/2015

Weekly Grant Funding Opportunities

Please feel free to send special funding search requests any time (susan_craft@ncbiotech.org).  Grant funding requests are included our regular research and include a fee of $100/hour. Also, let us know if any of your partners have submitted grant applications to funding announcements posted in the weekly grant alert emails.  We would love to hear of their successes!

Visit NCBiotech’s Funding Gateway page to get more information on funding announcements, links to opportunity search databases and grant development tips.

 

Announcements

Major Change to NIH SBIR/STTR Dates (Retroactive to Dec 5, 2014):

The NIH has just announced a major change to its SBIR/STTR proposal date cycle. In this case a "cycle" is synonymous with a proposal receipt date.

The NIH is extending their current PHS 2014-02 Omnibus Solicitation (PA-14-071) from 3 cycles to 4. That means the "non-aids" topics (whose 3rd cycle ended Dec 5, 2014) now has an additional 4th cycle with a receipt date of April 5, 2015. Likewise, the AIDS topics (whose 3rd cycle ends Jan 7, 2015) has a 4th cycle receipt date of May 7, 2015. This includes CDC, FDA and ACF. The current PHS 2014-02 Omnibus Solicitation will expire on May 8, 2015, so there will be no August receipt date.

So if you missed the Dec 5 receipt date, and/or if you want to make additional proposals to NIH, you are good through April 5, 2015 (non-aids) and May 7, 2015 (for aids related).

Read more here: http://grants.nih.gov/grants/guide/notice-files/NOT-OD-15-038.html


 

Upcoming Deadlines

Deadline: 1/24/2015

Agency: National Institutes of Health

Program: Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Etiology, Diagnosis, Pathophysiology, and Treatment (R21) 

Description: This Funding Opportunity Announcement (FOA) issued by the Office of Research on Women's Health (ORWH) and co-sponsoring Institutes and Centers (ICs) of the National Institutes of Health (NIH) encourages investigator(s)-initiated applications that propose to examine the etiology, diagnosis, pathophysiology, and treatment of chronic fatigue syndrome (CFS), sometimes referred to as myalgic encephalomyelitis (ME), in diverse groups and across the lifespan. Applications that address gaps in the understanding of the environmental and biological risk factors, the determinants of heterogeneity among patient populations, the common mechanisms influencing the multiple body systems that are affected in ME/CFS are encouraged. The NIH is particularly interested in funding interdisciplinary research that will enhance our knowledge of the disease process and provide evidence based solutions to improve the diagnosis, treatment, and quality of life of all persons with ME/CFS.

Award Amount: $200,000

Website: http://grants.nih.gov/grants/guide/pa-files/PAR-12-033.html

Eligibility: State, county or city governments; public and private institutes of higher education; school districts; small businesses; nonprofits; Native American tribal organizations; others


Deadline: 2/11/2015

Agency: North Carolina Biotechnology Center

Program: Collaborative Funding Grant

Description: The Collaborative Funding Grant (CFG) supports a university-company partnership that will advance a company’s technology toward the marketplace. This grant provides funds for a post-doctoral fellow or technician in a university lab to conduct research on a project of commercial interest. University investigators and companies first form the collaboration and then apply together through the university.

Award Amount: $100,000

Website: www.ncbiotech.org/research-grants/research-funding/collaborative-funding

Eligibility: Principal Investigators are eligible if: They hold a full-time tenure track faculty position at a North Carolina academic institution or a full-time permanent appointment at a non-profit research institution.  See guidelines for details on PIs who hold a position in the partnering company. Companies are eligible if: The company is a North Carolina-based company engaged in life science research, development or manufacturing with demonstrated IP owned or licensed by the company; and additional requirements as indicated in the 2015 Cycle 2 guidelines. OR The company is a national or multinational company with significant presence in North Carolina such as a research or manufacturing facility or regional headquarters. The collaboration must involve the North Carolina entity.


 

New Opportunities

Deadline: 1/30/2015

Agency: National Institutes of Health

Program: Developmental Origins of Health and Disease (DOHaD): Epigenetic Modification in Gametogenesis and Transgenerational Inheritance (R01)

Description: The purpose of this Funding Opportunity Announcement (FOA) is to encourage applications from the scientific community to support the development of comprehensive reference epigenomes for male and female gametes, and pre-implantation embryos after exposure to a particular environmental factor/insult. What is envisioned is the establishment of a compendium/atlas annotating epigenetic changes during various stages of spermatogenesis, oogenesis, and pre-implantation embryo development, the identification of the affected genes, and the characterization of any resulting phenotype in the offspring.

Award Amount: $ 250,000

Website: http://grants.nih.gov/grants/guide/pa-files/PAR-13-385.html

Eligibility: State, county or city governments; public and private institutes of higher education; school districts; small businesses; nonprofits; Native American tribal organizations; others


Deadline: 2/13/2015

Agency: National Kidney Foundation

Program: Young Investigator Program

Description: The National Kidney Foundation recognizes that future improvements in the treatment and prevention of kidney disease rest largely on the accomplishments of individuals now commencing their investigative work. To that end, the foundation has established a Young Investigator Grant Program to help alleviate this problem.

Through the annual program, NKF will award grants of up to $20,000 to support research projects in the field of nephrology and related disciplines to individuals who have completed their fellowship training and who hold a junior faculty position at a university-affiliated medical center in the United States.

Award Amount: $20,000

Website: http://grants.nih.gov/grants/guide/rfa-files/RFA-CA-15-001.html

Eligibility: To be eligible, applicants must hold a full-time appointment to a faculty position at a university or an equivalent position as a scientist on the staff of a research-oriented institution. In addition, the applicant's research and career goals must be directed toward the study of normal or abnormal kidney function or of diseases of the kidney and urinary tract.


Deadline: 2/13/2015

Agency: Lowe's

Program: Toolbox for Education grant

Description: Lowe’s Toolbox for Education Grant Program is dedicated to helping parent-teacher groups achieve more for their schools. Up to $5,000 will be given to K-12 public schools or parent groups (with 501c(3) status) to achieve project goals.

Award Amount: $5,000

Website: www.toolboxforeducation.com

Eligibility: Any individual public K-12 school or non-profit parent group associated with that public K-12 school. Parent groups that are applying (PTO, PTA, etc.) must have an independent EIN and official 501c(3) status from the IRS. If your group does not have 501c(3) status, please apply through your school. Pre-schools are not eligible.


Deadline: 2/15/2015

Agency: Leukemia & Lymphoma Society

Program: Translational Research Program

Description: The mission of the Leukemia & Lymphoma Society is to find a cure for leukemia, lymphoma, Hodgkin's disease, and myeloma and improve quality of life for patients and their families.

To advance these goals, the society's Translational Research Program was developed to encourage and provide early support for leukemia, lymphoma, and myeloma clinical research projects that aim to develop innovative approaches to treatment, diagnosis, and prevention. The program is designed to support new research that demonstrates high promise for translating basic biomedical knowledge to clinical application. The goal of translational research is to reduce the time between laboratory findings and actual treatment. Letters of Intent must be received no later than February 15, 2015. Upon review, selected applicants will be invited to submit full proposals by March 1, 2015.

Award Amount: $200,000

Website:www.lls.org/#/researchershealthcareprofessionals/academicgrants/translationalresearch/

Eligibility: To be eligible, applicants must hold an M.D., Ph.D., or equivalent degree and work at a domestic or foreign nonprofit organization such as a university, college, hospital, or laboratory.

grants
scroll back to top of page